CN104062428A - 一种检测循环肿瘤细胞的试剂盒 - Google Patents
一种检测循环肿瘤细胞的试剂盒 Download PDFInfo
- Publication number
- CN104062428A CN104062428A CN201410325174.5A CN201410325174A CN104062428A CN 104062428 A CN104062428 A CN 104062428A CN 201410325174 A CN201410325174 A CN 201410325174A CN 104062428 A CN104062428 A CN 104062428A
- Authority
- CN
- China
- Prior art keywords
- kit
- cell
- ctcs
- circulating tumor
- detects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 title claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 35
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 238000001514 detection method Methods 0.000 claims abstract description 16
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical group CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 210000003743 erythrocyte Anatomy 0.000 claims description 6
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 239000002210 silicon-based material Substances 0.000 claims description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 31
- 210000004027 cell Anatomy 0.000 abstract description 30
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 210000005266 circulating tumour cell Anatomy 0.000 description 43
- 239000011521 glass Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 7
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 125000003368 amide group Chemical group 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007705 epithelial mesenchymal transition Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000030808 Clear cell renal carcinoma Diseases 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 208000000265 Lobular Carcinoma Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000003714 breast lobular carcinoma Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 206010073251 clear cell renal cell carcinoma Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010073096 invasive lobular breast carcinoma Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- -1 microslide Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004375 physisorption Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 201000010106 skin squamous cell carcinoma Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
样本 | 肿瘤细胞数量(理论混入值) | 肿瘤细胞数量(实际检测值) | 检测率(%) |
1a | 50 | 45 | 90 |
1b | 50 | 46 | 92 |
1c | 50 | 48 | 96 |
2a | 100 | 92 | 92 |
2b | 100 | 95 | 95 |
2c | 100 | 97 | 97 |
3a | 200 | 190 | 95 |
3b | 200 | 198 | 99 |
3c | 200 | 186 | 93 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410325174.5A CN104062428B (zh) | 2014-07-09 | 2014-07-09 | 一种检测循环肿瘤细胞的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410325174.5A CN104062428B (zh) | 2014-07-09 | 2014-07-09 | 一种检测循环肿瘤细胞的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104062428A true CN104062428A (zh) | 2014-09-24 |
CN104062428B CN104062428B (zh) | 2016-08-17 |
Family
ID=51550235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410325174.5A Active CN104062428B (zh) | 2014-07-09 | 2014-07-09 | 一种检测循环肿瘤细胞的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104062428B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104897750A (zh) * | 2015-06-11 | 2015-09-09 | 江汉大学 | 循环肿瘤细胞检测探针及制备方法及应用诊断传感器 |
CN106498024A (zh) * | 2016-10-21 | 2017-03-15 | 上海市第人民医院 | 个体化外周血循环肿瘤细胞联合肿瘤标记物检测对晚期结肠癌患者化疗疗效的评估 |
CN106645724A (zh) * | 2016-12-21 | 2017-05-10 | 上海浦美生物医药科技有限公司 | 循环肿瘤细胞表面标志分子磷脂酰肌醇蛋白聚糖‑3的检测方法 |
CN107335410A (zh) * | 2016-08-16 | 2017-11-10 | 上海浦美生物医药科技有限公司 | 纳米基底膜的制备方法 |
CN107389937A (zh) * | 2017-07-20 | 2017-11-24 | 上海长海医院 | 一种快速检测体液中肿瘤细胞的试剂盒及其检测方法和应用 |
CN107462724A (zh) * | 2016-08-30 | 2017-12-12 | 上海浦美生物医药科技有限公司 | 血液中循环肿瘤细胞的检测方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108489795A (zh) * | 2018-03-21 | 2018-09-04 | 上海浦美生物医药科技有限公司 | 一种尿液肿瘤细胞富集和检测的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011108909A2 (en) * | 2010-03-05 | 2011-09-09 | Samsung Electronics Co., Ltd. | Method and kit for isolating target cell |
US20120244531A1 (en) * | 2011-03-25 | 2012-09-27 | M&D, Inc | Method for providing information for diagnosing cancer using quantitative real-time pcr and kit for diagnosing cancer for the same |
WO2013086428A1 (en) * | 2011-12-09 | 2013-06-13 | The Scripps Research Institute | Apparatus, system and method for identifying circulating tumor cells |
-
2014
- 2014-07-09 CN CN201410325174.5A patent/CN104062428B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011108909A2 (en) * | 2010-03-05 | 2011-09-09 | Samsung Electronics Co., Ltd. | Method and kit for isolating target cell |
US20120244531A1 (en) * | 2011-03-25 | 2012-09-27 | M&D, Inc | Method for providing information for diagnosing cancer using quantitative real-time pcr and kit for diagnosing cancer for the same |
WO2013086428A1 (en) * | 2011-12-09 | 2013-06-13 | The Scripps Research Institute | Apparatus, system and method for identifying circulating tumor cells |
Non-Patent Citations (4)
Title |
---|
SANG-KWON LEE ET AL: "Nanowire Substrate-based Laser Scanning Cytometry for Quantitation of Circulating Tumor Cells", 《NANO LETT》 * |
WEIQIANG CHEN ET AL: "Nanoroughened Surfaces for Efficient Capture of Circulating Tumor Cells without Using Capture Antibodies", 《ACS NANO》 * |
赖梦君: "基于免疫亲和原理的循环肿瘤细胞富集/筛选芯片的构建及应用", 《中国优秀硕士学位论文全文数据库》 * |
钟文英等: "新型包覆数目可控的(CdTe/ZnS)nSiO2微球制备及细胞成像", 《无机化学学报》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104897750A (zh) * | 2015-06-11 | 2015-09-09 | 江汉大学 | 循环肿瘤细胞检测探针及制备方法及应用诊断传感器 |
CN107335410A (zh) * | 2016-08-16 | 2017-11-10 | 上海浦美生物医药科技有限公司 | 纳米基底膜的制备方法 |
CN107462724A (zh) * | 2016-08-30 | 2017-12-12 | 上海浦美生物医药科技有限公司 | 血液中循环肿瘤细胞的检测方法 |
CN106498024A (zh) * | 2016-10-21 | 2017-03-15 | 上海市第人民医院 | 个体化外周血循环肿瘤细胞联合肿瘤标记物检测对晚期结肠癌患者化疗疗效的评估 |
CN106645724A (zh) * | 2016-12-21 | 2017-05-10 | 上海浦美生物医药科技有限公司 | 循环肿瘤细胞表面标志分子磷脂酰肌醇蛋白聚糖‑3的检测方法 |
CN107389937A (zh) * | 2017-07-20 | 2017-11-24 | 上海长海医院 | 一种快速检测体液中肿瘤细胞的试剂盒及其检测方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104062428B (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104062428B (zh) | 一种检测循环肿瘤细胞的试剂盒 | |
Deng et al. | Circulating tumor cell isolation for cancer diagnosis and prognosis | |
CN102925337B (zh) | 一种微流体细胞捕获芯片及其制备方法 | |
CN110095608A (zh) | 基于磁性分离和dna自组装的肿瘤外泌体纳米荧光传感器 | |
CN109153968A (zh) | 从生物流体样品中分离细胞外囊泡(ev) | |
CN106093392A (zh) | 一种尿液外泌体分离、富集及检测的集成检测方法及检测芯片 | |
CN103424555B (zh) | 一种输血前配合试验的试剂组及其试验方法 | |
US20080050769A1 (en) | Method for detecting bioparticles | |
CN107085107A (zh) | 一种检测食管鳞状细胞癌循环肿瘤细胞的微流体系统及其应用 | |
JP6437009B2 (ja) | 循環腫瘍細胞(ctc)の検出方法 | |
CN106366196A (zh) | 一种EpCAM抗体免疫磁珠及其制备方法 | |
CN106244553A (zh) | 循环肿瘤细胞的分离和检测方法 | |
CN103031276A (zh) | 一种获取循环肿瘤单细胞的方法 | |
CN104807996A (zh) | 细胞表面标志分子用于检测肝癌循环肿瘤细胞的用途 | |
WO2020206891A1 (zh) | 己糖激酶2用于体液样本中稀有肿瘤细胞检测及试剂盒 | |
WO2016111619A1 (en) | Methods for detecting a marker for active tuberculosis | |
CN104990905B (zh) | 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒 | |
CN106970225A (zh) | 一种应用cd45免疫荧光联合cep 8探针鉴定循环肿瘤细胞的试剂盒及其应用 | |
CN106970224A (zh) | 一种应用cd45免疫荧光联合cep探针鉴定循环肿瘤细胞的试剂盒及其应用 | |
CN206082559U (zh) | 一种用于外泌体分离、富集和检测的微流体芯片 | |
CN205067292U (zh) | 一种循环肿瘤细胞检测试剂盒 | |
CN107525920B (zh) | 聚离子液体磁性纳米复合物及其对痕量循环肿瘤细胞特异性富集和检测的应用 | |
CN111351937A (zh) | 一种mmr蛋白表达缺失检测试剂盒及其检测方法 | |
CN111893023A (zh) | 肿瘤细胞捕获装置及其制备、应用 | |
Wang et al. | Antibody-modified reduced graphene oxide film for circulating tumor cell detection in early-stage prostate cancer patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171013 Address after: 210032, Jiangsu province Nanjing high tech Development Zone, Spark Road No. 10 ding industry biological building C block 207 room Patentee after: Nanjing to Thailand biomedical science and Technology Co., Ltd. Address before: 210003 Jiangsu city of Nanjing province Nanjing City Zhong Fu 1-1 No. Second Hospital of Nanjing City Co-patentee before: Wan Yuan Patentee before: Zheng Qin Co-patentee before: Wang Lixue |